Jilin Zixin Pharmaceutical Industrial

Jilin Zixin Pharmaceutical Industrial is a company listed under the stock ticker 002118 (CN).

View the org chart displaying its 5 main executives

Most searched biographies at Jilin Zixin Pharmaceutical Industrial

• Xiangjin Meng, General Manager
• Youshun Feng, Chairman of the Board
• Feng Tian, Director

Create your alert
to follow the executive moves at Jilin Zixin Pharmaceutical Industrial.

Jilin Zixin Pharmaceutical Industrial has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Jilin Zixin Pharmaceutical Industrial

Social media about Jilin Zixin Pharmaceutical Industrial

• Jilin Zixin Pharmaceutical Industrial on Wikipedia, Google News & Yahoo Finance
• Jilin Zixin Pharmaceutical Industrial on LinkedIn, Twitter & YouTube

Call Jilin Zixin Pharmaceutical Industrial at +86 431 ...

View the org chart

Register to receive your alert

Report an error